Reply to “Beyond Fortnightly Convenience: A VALIDATE Pathway for TE‐8105 in Global Obesity Care”
The Journal of Clinical Pharmacology · 2026-10 · 66 (10)
DOI: 10.1002/jcph.70317 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Clinical Pharmacology, online erschienen am 22.10.2026. Verfasst von Ya-Shan Chuang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Immunwork, Inc, Taipei City, Taiwan. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Immunwork, Inc, Taipei City, Taiwan.
- CMAX Clinical Research Pty Ltd, Adelaide, Australia.
- Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
- T-E Meds, Inc., Taipei City, Taiwan.
- Centre for Medicine Use and Safety, Monash University, Melbourne, Australia.
ORCID-Profile: Jon D Wright, Tse Wen Chang, Thomas M Polasek
Zitieren
APA
Chuang, Y. S., Wright, J. D., Wong, M. T., Paneliya, K. J., Yang, W. S., Chu, H. M., Chang, T. W., & Polasek, T. M. (2026). Reply to “Beyond Fortnightly Convenience: A VALIDATE Pathway for TE‐8105 in Global Obesity Care”. The Journal of Clinical Pharmacology, 66(10). https://doi.org/10.1002/jcph.70317
Vancouver
Chuang YS, Wright JD, Wong MT, Paneliya KJ, Yang WS, Chu HM, et al. Reply to “Beyond Fortnightly Convenience: A VALIDATE Pathway for TE‐8105 in Global Obesity Care”. The Journal of Clinical Pharmacology. 2026;66(10). doi:10.1002/jcph.70317
BibTeX
@article{Chuang2026,
author = {Chuang, Ya-Shan and Wright, Jon D and Wong, Mun-Teng and Paneliya, Kushal J and Yang, Wei-Shiung and Chu, Hsing-Mao and Chang, Tse Wen and Polasek, Thomas M},
title = {Reply to “Beyond Fortnightly Convenience: A VALIDATE Pathway for TE‐8105 in Global Obesity Care”},
journal = {The Journal of Clinical Pharmacology},
year = {2026},
volume = {66},
number = {10},
doi = {10.1002/jcph.70317}
}
EUVIMED